Health
Pfizer expects to cut COVID-19 vaccine production time by close to 50% as production ramps up, efficiencies increase – USA TODAY
As the nation revs up its vaccination programs, the increase could help relieve bottlenecks caused by vaccine shortages.
New research suggests the COVID-19 vaccine made by Pfizer and BioNTech can still work against a mutated coronavirus. Two easier-to-spread new variants of the virus have the world on edge. One was first discovered in Britain and South Africa. (Jan 8)
AP Domestic
Pfizer expects to nearly cut in half the amount of time it takes to produce a batch of COVID-19 vaccine, from 110 days to an average of 60, as it makes the process more efficient and production is built out, the company told USA TODAY.
As…
-
General20 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General18 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News21 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
General6 hours agoByford rail extension opening marks final stage of Perth Metronet